Power Corp Of Canada Regeneron Pharmaceuticals, Inc. Transaction History

Power Corp Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.23 Million - $1.4 Million	-1,591 Reduced 20.75%	6,078 $5.34 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $5.37 Million - $6.37 Million	7,669 New	7,669 $5.51 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $5.22 Million - $6.34 Million	7,669 New	7,669 $6.3 Million
Q3 2022 Nov 18, 2022	BUY	$573.97 - $724.32 $1.99 Million - $2.51 Million	3,460 New	3,460 $2.38 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $416,746 - $561,518	760 Added 28.15%	3,460 $2.05 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1.61 Million - $1.89 Million	2,700 New	2,700 $1.89 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

Stay updated on Power Corp Of Canada with notifications on news.